Scolaris Content Display Scolaris Content Display

Base de datos Cochrane de Revisiones Sistemáticas Protocolo - Intervención

Prebiotics for the prevention of hyperbilirubinaemia in neonates

Declaraciones de intereses de los autores

Versión publicada: 20 julio 2017 Historial de versiones

https://doi.org/10.1002/14651858.CD012731

Esta versión no es la más reciente

ver la versión actual 13 agosto 2019

Contenido relacionado

Ir a:

Revisiones y protocolos relacionados

Topics

Temas

Guidelines for phototherapy in infants at ≥ 35 weeks' gestation. (American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297.)
Figuras y tablas -
Figure 1

Guidelines for phototherapy in infants at ≥ 35 weeks' gestation. 

(American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297.)

Ir a la figura del protocoloAbrir en una pestaña nueva

Suggested guidelines for initiating phototherapy or exchange transfusion in premature infants.(Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. Journal of Perinatology 2012;32:660‐664.)
Figuras y tablas -
Figure 2

Suggested guidelines for initiating phototherapy or exchange transfusion in premature infants.

(Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. Journal of Perinatology 2012;32:660‐664.)

Ir a la figura del protocoloAbrir en una pestaña nueva